ENANTA PHARMACEUTICALS INC Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENANTA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ENANTA PHARMACEUTICALS INC for February 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Payment of Exercise | F | 88.88 | 20,730 | 1,842,482 | 631,194 | 651.9 K to 631.2 K (-3.18 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 36,000 | 0 | 651,924 | 615.9 K to 651.9 K (+5.84 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 14,400 | 0 | 615,924 | 601.5 K to 615.9 K (+2.39 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Option Exercise | M | 14.18 | 8,772 | 124,387 | 5,149 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Option Exercise | M | 14.00 | 6,956 | 97,384 | 13,926 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Option Exercise | M | 11.77 | 10,249 | 120,631 | 3,672 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Payment of Exercise | F | 88.88 | 6,993 | 621,538 | 310,673 | 317.7 K to 310.7 K (-2.20 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Grant | A | 0.00 | 11,250 | 0 | 317,666 | 306.4 K to 317.7 K (+3.67 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Grant | A | 0.00 | 4,500 | 0 | 306,416 | 301.9 K to 306.4 K (+1.49 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Sell | S | 90.07 | 6,297 | 567,173 | 301,916 | 308.2 K to 301.9 K (-2.04 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Sell | S | 91.24 | 171 | 15,602 | 308,213 | 308.4 K to 308.2 K (-0.06 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Sell | S | 90.11 | 2,707 | 243,936 | 308,384 | 311.1 K to 308.4 K (-0.87 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Sell | S | 89.50 | 18,971 | 1,697,878 | 311,091 | 330.1 K to 311.1 K (-5.75 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Sell | S | 88.66 | 5,835 | 517,321 | 330,062 | 335.9 K to 330.1 K (-1.74 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Buy | M | 14.18 | 8,772 | 124,387 | 335,897 | 327.1 K to 335.9 K (+2.68 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Buy | M | 14.00 | 6,956 | 97,384 | 327,125 | 320.2 K to 327.1 K (+2.17 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Buy | M | 11.77 | 10,249 | 120,631 | 320,169 | 309.9 K to 320.2 K (+3.31 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | M | 29.02 | 7,500 | 217,650 | 0 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | M | 25.58 | 3,728 | 95,362 | 0 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | M | 25.58 | 2,272 | 58,118 | 3,728 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Sell | S | 90.07 | 11,228 | 1,011,301 | 0 | 11.2 K to 0 (-100.00 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Buy | M | 29.02 | 7,500 | 217,650 | 11,228 | 3.7 K to 11.2 K (+201.18 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Buy | M | 25.58 | 3,728 | 95,362 | 3,728 | 0 to 3.7 K |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Sell | S | 90.03 | 2,272 | 204,552 | 0 | 2.3 K to 0 (-100.00 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Buy | M | 25.58 | 2,272 | 58,118 | 2,272 | 0 to 2.3 K |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Option Exercise | M | 23.40 | 5,000 | 117,000 | 1,546 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Option Exercise | M | 23.40 | 2,734 | 63,976 | 6,546 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Sell | S | 90.00 | 5,000 | 450,000 | 0 | 5 K to 0 (-100.00 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Buy | M | 23.40 | 5,000 | 117,000 | 5,000 | 0 to 5 K |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Sell | S | 90.02 | 2,734 | 246,102 | 0 | 2.7 K to 0 (-100.00 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Buy | M | 23.40 | 2,734 | 63,976 | 2,734 | 0 to 2.7 K |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Ocain Tim | Senior Vice Preside ... | Payment of Exercise | F | 88.88 | 4,580 | 407,070 | 17,547 | 22.1 K to 17.5 K (-20.70 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Ocain Tim | Senior Vice Preside ... | Payment of Exercise | F | 88.88 | 4,580 | 407,070 | 17,547 | 22.1 K to 17.5 K (-20.70 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Ocain Tim | Senior Vice Preside ... | Grant | A | 0.00 | 10,000 | 0 | 22,127 | 12.1 K to 22.1 K (+82.46 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Ocain Tim | Senior Vice Preside ... | Grant | A | 0.00 | 10,000 | 0 | 22,127 | 12.1 K to 22.1 K (+82.46 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Ocain Tim | Senior Vice Preside ... | Grant | A | 0.00 | 4,000 | 0 | 12,127 | 8.1 K to 12.1 K (+49.22 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Ocain Tim | Senior Vice Preside ... | Grant | A | 0.00 | 4,000 | 0 | 12,127 | 8.1 K to 12.1 K (+49.22 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Payment of Exercise | F | 88.88 | 5,356 | 476,041 | 10,394 | 15.8 K to 10.4 K (-34.01 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Payment of Exercise | F | 88.88 | 5,356 | 476,041 | 10,394 | 15.8 K to 10.4 K (-34.01 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 11,250 | 0 | 15,750 | 4.5 K to 15.8 K (+250.00 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 11,250 | 0 | 15,750 | 4.5 K to 15.8 K (+250.00 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 4,500 | 0 | 4,500 | 0 to 4.5 K |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 4,500 | 0 | 4,500 | 0 to 4.5 K |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Sell | S | 95.28 | 3,270 | 311,562 | 23,978 | 27.2 K to 24 K (-12.00 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Sell | S | 95.28 | 3,270 | 311,562 | 23,978 | 27.2 K to 24 K (-12.00 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Payment of Exercise | F | 88.88 | 4,579 | 406,982 | 27,248 | 31.8 K to 27.2 K (-14.39 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Payment of Exercise | F | 88.88 | 4,579 | 406,982 | 27,248 | 31.8 K to 27.2 K (-14.39 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 10,000 | 0 | 31,827 | 21.8 K to 31.8 K (+45.81 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 10,000 | 0 | 31,827 | 21.8 K to 31.8 K (+45.81 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 4,000 | 0 | 21,827 | 17.8 K to 21.8 K (+22.44 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 4,000 | 0 | 21,827 | 17.8 K to 21.8 K (+22.44 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Payment of Exercise | F | 88.88 | 4,890 | 434,623 | 90,228 | 95.1 K to 90.2 K (-5.14 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Payment of Exercise | F | 88.88 | 4,890 | 434,623 | 90,228 | 95.1 K to 90.2 K (-5.14 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Grant | A | 0.00 | 10,500 | 0 | 95,118 | 84.6 K to 95.1 K (+12.41 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Grant | A | 0.00 | 10,500 | 0 | 95,118 | 84.6 K to 95.1 K (+12.41 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Grant | A | 0.00 | 4,200 | 0 | 84,618 | 80.4 K to 84.6 K (+5.22 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Grant | A | 0.00 | 4,200 | 0 | 84,618 | 80.4 K to 84.6 K (+5.22 %) |